bremelanotide [1485]
bremelanotide
| SMILES | CCCCC(NC(C)=O)C(=O)NC1CC(=O)NCCCCC(C(=O)O)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CCCN=C(N)N)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2c[nH]cn2)NC1=O |
| InChIKey | FFHBJDQSGDNCIV-UHFFFAOYSA-N |
| Sequence | None |
| HELM | PEPTIDE1{H.[dF].R.W.K}|PEPTIDE2{[ac].[Nle].D}$PEPTIDE2,PEPTIDE1,3:R2-1:R1|PEPTIDE2,PEPTIDE1,3:R3-5:R3$$$ |
Chemical Properties
| Hydrogen bond acceptors | None |
| Hydrogen bond donors | None |
| Rotatable bonds | None |
| Log P | None |
| Molecular weight (Da) | None |
Database connections
|
|
No bioactivity data available.
bremelanotide
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
|
|